Related Experiment Video
Updated: Aug 5, 2026
08:58
Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
Published on: March 11, 2017
Towards Bayesian-based quantitative adverse outcome pathways using in vitro data from open literature and continuous
Robin Durnik1, Tereza Juchelkova1, Helge Hecht1
1RECETOX, Faculty of Science, Masaryk University, Brno, 611 37, Czech Republic.
Summary
This study developed a new Bayesian model using continuous variables and public data to predict liver fibrosis from in vitro results. This advances non-animal toxicology by quantifying key event relationships in adverse outcome pathways.
Area of Science:
- Toxicology and Computational Biology
- Adverse Outcome Pathway (AOP) modeling
Background:
- The field of toxicology is transitioning towards non-animal testing methods.
- Quantitative Adverse Outcome Pathways (qAOPs) are crucial for predicting adverse health effects but are currently limited in number.
- Existing Bayesian qAOPs often use discretized variables and underutilize available data.
Purpose of the Study:
- To develop an innovative Bayesian-based quantitative model using continuous variables for predicting liver fibrosis.
- To leverage existing data from public literature and databases for model development.
- To establish a workflow for knowledge extraction from scientific literature and chemical databases.
Main Methods:
- Developed a novel framework for knowledge identification, organization, and extraction from scientific literature and chemical databases.
- Constructed a Bayesian model utilizing continuous variables to quantify Key Event Relationships (KERs) in AOPs.
- Integrated in vitro data with in vivo information from the Open TG-GATEs database.
Main Results:
- The model successfully predicts the expression fold change of hepatic stellate cell activation markers (aSMA and COL1A1) based on tissue injury.
- Identified a biologically relevant COL1A1 fold change range indicating activated stellate cells and high liver fibrosis risk.
- Demonstrated the integration of public data and continuous variables in a Bayesian framework for predictive toxicology.
Conclusions:
- This study presents a successful case example of building a Bayesian-based quantitative model for predicting liver fibrosis using continuous variables and public data.
- The developed framework and model represent a significant advancement in predicting liver fibrosis from in vitro data, supporting non-animal testing approaches.
- The approach enhances the utility of existing toxicological data for developing more predictive and robust qAOPs.
Related Concept Videos
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...